CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
Pharmacist led behavioral change techniquebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06744738
NCT06744738N/ACompleted

Pharmacist-led Intervention on Hemodialysis Patients' Therapy Adherence

Thuraya Safaa Ibrahim·interventional·Posted Dec 20, 2024·Updated Dec 20, 2024

In Brief

A clinical study evaluating Pharmacist led behavioral change technique for Hemodialysis and End Stage Renal Disease Requiring Hemodialysis. Completed, enrolled 72 participants across 1 site.

Detailed Summary

A parallel-group, cluster-randomized, controlled trial designed to evaluate if hemodialysis patients benefit from BCT. The study includes two groups: usual care and pharmacist-led intervention groups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesIraq
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedDec 20, 2024
Enrollment StartFeb 2, 2024
Primary CompletionJun 25, 2024
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 1.5 years ago

Interventions

Pharmacist led behavioral change techniquebehavioral

The intervention was developed based on the behavior change technique taxonomy (v1). This intervention was designed to improve adherence to all therapeutic aspects of hemodialysis patients, including the dialysis program, medications, diet, and fluids. Additionally, the effect of the pharmacist intervention on physiological indices (serum potassium, total calcium, phosphate, IDWG, and hemoglobin) was examined. The program was explicitly created for implementation in an actual setting, ensuring that the time allocation for participants and facilitators (the party responsible for conducting the PL-BCT) remained reasonable in most contexts. The BCT components were developed after the identification and coding of the BCTs from previous interventional studies that contain behavioral components and result in positive effects on one or more hemodialysis patients' adherence domains toward their therapeutic regimen (dialysis program, medications, diet, and fluid).